Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-11-15 Vasista Vittal Chief Financial Officer Sale −2,042 $62.23 $127K 130,583
2018-11-15 Vasista Vittal Chief Financial Officer Sale −700 $63.05 $44K 129,883
2018-11-15 Vasista Vittal Chief Financial Officer Sale −100 $64.10 $6K 129,783
2018-11-12 Mills Kenneth T. President and CEO Sale −13,586 $62.85 $854K 292,414
2018-11-12 Mills Kenneth T. President and CEO Sale −6,214 $63.65 $396K 286,200
2018-11-12 Mills Kenneth T. President and CEO Sale −200 $64.30 $13K 286,000
2018-11-07 Christmas Patrick J. SVP, General Counsel Sale −15,000 $72.06 $1.1M 2,669
2018-11-05 Yoo Stephen Chief Medical Officer Exercise or conversion +20,414 $0.85 $17K 20,414
2018-11-05 Yoo Stephen Chief Medical Officer Sale −3,413 $66.26 $226K 17,001
2018-11-05 Yoo Stephen Chief Medical Officer Sale −4,820 $67.14 $324K 12,181
2018-11-05 Yoo Stephen Chief Medical Officer Sale −3,700 $68.22 $252K 8,481
2018-11-05 Yoo Stephen Chief Medical Officer Sale −3,854 $69.54 $268K 4,627
2018-11-05 Yoo Stephen Chief Medical Officer Sale −4,627 $69.97 $324K 0
2018-11-05 Yoo Stephen Chief Medical Officer Exercise or conversion · Employee Stock Option (Right to Buy) −20,414 81,658
2018-11-05 Mills Kenneth T. President and CEO Sale −3,500 $66.29 $232K 322,500
2018-11-05 Mills Kenneth T. President and CEO Sale −4,816 $67.16 $323K 317,684
2018-11-05 Mills Kenneth T. President and CEO Sale −3,635 $68.27 $248K 314,049
2018-11-05 Mills Kenneth T. President and CEO Sale −3,340 $69.47 $232K 310,709
2018-11-05 Mills Kenneth T. President and CEO Sale −4,709 $69.92 $329K 306,000
2018-11-02 Vasista Vittal Chief Financial Officer Exercise or conversion +32,908 $13.09 $431K 170,191

Page 35 of 43 · 852 trades